Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-08

Clinical Trial Update: Tau Networks in Psychotic Alzheimer's Disease

View source ↗

Summary

A clinical trial sponsored by Northwell Health is evaluating tau-network therapy for Alzheimer's disease with delusions/psychosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northwell Health | Conditions: Alzheimer Disease, Alzheimer Disease With Delusions | Status: RECRUITING